Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Harms

Showing results (141-150 of 154) with videos related to

Pageof 16
Sort By:
Digestive Diseases and Sciences|August 5, 1998
Epithelial cell proliferative activity of Barrett's esophagus: methodology and correlation with traditional cancer risk markersF T Peters, S Ganesh, E J Kuipers, et al.
European Journal of Public Health|June 18, 2015
The burden of Lyme borreliosis expressed in disability-adjusted life yearsCees C van den Wijngaard, Agnetha Hofhuis, Margriet G Harms, et al.
Immunobiology|December 6, 2014
CD16⁺ monocytes with smooth muscle cell characteristics are reduced in human renal chronic transplant dysfunctionM Boersema, J C van den Born, J van Ark, et al.
Emerging Infectious Diseases|June 26, 2014
Human exposure to tickborne relapsing fever spirochete Borrelia miyamotoi, the NetherlandsManoj Fonville, Ingrid H M Friesema, Paul D Hengeveld, et al.
The Journal of Infection|June 23, 2020
A single dose of doxycycline after an ixodes ricinus tick bite to prevent Lyme borreliosis: An open-label randomized controlled trialM G Harms, A Hofhuis, H Sprong, et al.
The Journal of Pathology|March 19, 2008
miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expressionM Wang, L P Tan, M K Dijkstra, et al.
The Lancet Regional Health. Europe|September 24, 2021
Prevalence of persistent symptoms after treatment for lyme borreliosis: A prospective observational cohort studyJeanine Ursinus, Hedwig D Vrijmoeth, Margriet G Harms, et al.
The Lancet Regional Health. Europe|March 27, 2023
Corrections to "Prevalence of persistent symptoms after treatment for lyme borreliosis: a prospective observational cohort study" [The Lancet Regional Health - Europe 6 (2021) 100142]Jeanine Ursinus, Hedwig D Vrijmoeth, Margriet G Harms, et al.
BMC Infectious Diseases|April 17, 2019
Prevalence and determinants of persistent symptoms after treatment for Lyme borreliosis: study protocol for an observational, prospective cohort study (LymeProspect)Hedwig D Vrijmoeth, Jeanine Ursinus, Margriet G Harms, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 16, 2024
Evaluation and 1-year follow-up of patients presenting at a Lyme borreliosis expertise centre: a prospective cohort study with validated questionnairesF R van de Schoor, M E Baarsma, S A Gauw, et al.
Pageof 16

Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Digestive Diseases and Sciences|August 5, 1998
Epithelial cell proliferative activity of Barrett's esophagus: methodology and correlation with traditional cancer risk markersF T Peters, S Ganesh, E J Kuipers, et al.
European Journal of Public Health|June 18, 2015
The burden of Lyme borreliosis expressed in disability-adjusted life yearsCees C van den Wijngaard, Agnetha Hofhuis, Margriet G Harms, et al.
Immunobiology|December 6, 2014
CD16⁺ monocytes with smooth muscle cell characteristics are reduced in human renal chronic transplant dysfunctionM Boersema, J C van den Born, J van Ark, et al.
Emerging Infectious Diseases|June 26, 2014
Human exposure to tickborne relapsing fever spirochete Borrelia miyamotoi, the NetherlandsManoj Fonville, Ingrid H M Friesema, Paul D Hengeveld, et al.
The Journal of Infection|June 23, 2020
A single dose of doxycycline after an ixodes ricinus tick bite to prevent Lyme borreliosis: An open-label randomized controlled trialM G Harms, A Hofhuis, H Sprong, et al.
The Journal of Pathology|March 19, 2008
miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expressionM Wang, L P Tan, M K Dijkstra, et al.
The Lancet Regional Health. Europe|September 24, 2021
Prevalence of persistent symptoms after treatment for lyme borreliosis: A prospective observational cohort studyJeanine Ursinus, Hedwig D Vrijmoeth, Margriet G Harms, et al.
The Lancet Regional Health. Europe|March 27, 2023
Corrections to "Prevalence of persistent symptoms after treatment for lyme borreliosis: a prospective observational cohort study" [The Lancet Regional Health - Europe 6 (2021) 100142]Jeanine Ursinus, Hedwig D Vrijmoeth, Margriet G Harms, et al.
BMC Infectious Diseases|April 17, 2019
Prevalence and determinants of persistent symptoms after treatment for Lyme borreliosis: study protocol for an observational, prospective cohort study (LymeProspect)Hedwig D Vrijmoeth, Jeanine Ursinus, Margriet G Harms, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 16, 2024
Evaluation and 1-year follow-up of patients presenting at a Lyme borreliosis expertise centre: a prospective cohort study with validated questionnairesF R van de Schoor, M E Baarsma, S A Gauw, et al.
Pageof 16